Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 1998, p. 3217-3222, Vol. 36, No. 11
Department of Microbiology and Immunology,
University of South Carolina, School of Medicine, Columbia, South
Carolina 29208,1 and
Development and Engineering
Center, U.S. Army Chemical Research, Aberdeen Proving Ground,
Edgewood, Maryland 21010-54232
Received 16 April 1998/Returned for modification 1 July
1998/Accepted 7 August 1998
Molecular and chemical characteristics often provide complementary
information in the differentiation of closely related organisms. The
genus Brucella consists of a highly conserved group of
organisms. Identification of the four species pathogenic in humans
(Brucella melitensis, Brucella abortus,
Brucella suis, and Brucella canis) is
problematic for many clinical laboratories that depend primarily on
serology and phenotypic characteristics to differentiate species. PCR
amplification of the 16S-23S ribosomal DNA interspace region was
evaluated for species-specific polymorphism. B. abortus,
B. melitensis, B. suis, and B. canis produced identical PCR interspace profiles. However, these
PCR products were unique to brucellae, allowing them to be readily
distinguished from other gram-negative bacteria (including
Bartonella spp. and Agrobacterium spp.).
Carbohydrate profiles differentiated B. canis from the
other three Brucella species due to the absence of the rare
amino sugar quinovosamine in the three other species. PCR of the
rRNA interspace region is useful in identification of the genus
Brucella, while carbohydrate profiling is capable of
differentiating B. canis from the other Brucella species.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification of Brucella by
Ribosomal-Spacer-Region PCR and Differentiation of Brucella
canis from Other Brucella spp. Pathogenic for Humans by
Carbohydrate Profiles
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, University of South Carolina, School
of Medicine, Columbia, SC 29208. Phone: (803) 733-3288. Fax:
(803) 733-3192. E-mail: afox{at}med.scarolina.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|